WASHINGTON - There's been no indication of when the US Food and Drug Authority will approve the Johnson & Johnson vaccine.
This as concerns continue about the delay in giving it the green light.
Health experts and governments are worried about the shelf life of their existing stock.
Should the FDA approve the vaccine, South Africa will be able to release a million more doses stuck in Gqeberha, in the Eastern Cape.
eNCA's Washington correspondent Simon Marks shares more details in the video above.